The UK National Health Service (NHS) is set to initiate the trial of Galleri blood test that can potentially detect over 50 types of cancers.
Developed by GRAIL, the test is capable of detecting early-stage cancers through a simple blood test.
In research on patients with cancer signs, the test identified many types like head and neck, ovarian, pancreatic, oesophageal and some blood cancers, which are difficult to diagnose early.
Totally plc (LON:TLY) addresses the challenges of increased demand on healthcare services by delivering high-quality planned, urgent and insourcing healthcare across the UK and Ireland.